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The self-ordering of C60??????????????????????????????????? ???????????????????????????????????????????
???? ????????????? ?????? ????????????? ???????????? ???? ???????? ???????? ???? ????????????? ???????? ???? ????
????????????????????????????????????????????????????????????60??????????????60+Dox) was evaluated in vitro 
??????????????????????????????????????????????????????????????????????????????60? ????????????????????????
???????????????? ???????????????????????????????60????????????? ????????????????????????????????????????????
? ? ? ? ? ? ? ? ????60??????????????????????????????????????????????????????????????????????.
T ??? ??????????? ???????????? ??? ????????? ?60fullerene requires a comprehensive study of possible displays of its toxic effect in the 
whole organism, as well as in the isolated cells. This 
allotropic form of nanocarbon possesses a unique 
structure, physical and chemical properties and bio-
logical activity in vitro and in vivo [1-3]. However, 
there are several contradictory reports on C60 fullere-
ne genotoxicity [4-8]. 
Numerous studies with using different cell 
types revealed that C60 fullerenes possess genotoxic 
activity. Data obtained from comet assay indicate 
that aqueous suspension of colloid C60 fullerenes 
induced DNA strand breaks and oxidative DNA 
damages in concentration-dependent manner [9–11]. 
Genotoxicity of C60??????????? ????????????????????
micronuclei test in vitro [12]. It is assumed that basic 
mechanisms of its toxic effect are lipid peroxidation, 
oxidative stress dissemination and genotoxicity [13]. 
On the other hand, there are few studies 
showing no mutagenic effect of C60 fullerene in vivo
and in vitro. For example, C60 fullerene did not in-
?????????????????????????????????????????????????-
cantly increased the level of FPG sensitive sites/oxi-
dized purines determined by a comet assay in lung 
epithelial cell line [10]. No increase in the level of in
vitro chromosomal aberrations and in vivo micronu-
clei was observed in the cytogenetic test at any C60 
fullerene nanoparticle dose regardless of metabolic 
activation and irradiation [14].
???????????????????????????????????60 molecules 
depends on their concentration in the medium, sur-
?????????????????????????????????????????????????-
?????????????????????????????????????60 fullerene and 
?????????????????????????????????????????????????? ???
various cell lines [17]. Thus, the genotoxicity of C60
fullerene in vitro and in vivo strongly depends on the 
size of its aggregates, dose administration, type of 
cells and duration of exposure.
At the same time, there are data suggesting that 
?60 fullerene possesses an ability to prevent oxida-
tive stress dissemination in thymocytes [18, 19]. 
???????????????????????????????60 fullerene is unable 
to penetrate cell membranes [20, 21]. Some special 
????????????????????????????????60 fullerenes, such as 
anticancer activity, were detected [22, 23]. 
Doxorubicin (Dox), the antibiotic of anthracy-
cline class, is one of the most common therapeutic 
agents in cancer chemotherapy [24]. Its main draw-
??????????????????????????????????????????????????
considerably limit the effectiveness of the therapeu-
tic action. Therefore, to improve the effectiveness of 
Dox therapeutic action the alternative cancer treat-
ments are to be developed, including purposeful 
search for new agents such as targeted carriers and 
agents which would promote minimization of Dox 
side effects. One can assume that immobilization of 
Dox on C60 fullerene [25] prevents its toxic action 
towards normal cells and enhances its uptake by the 
target cells that is important for the biomedical ap-
plication of C60 fullerene-drug conjugates [26].
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The aim of this study was to evaluate and 
compare in vitro genotoxic effects of C60 fullerene, 
doxopubicin, and their complex (C60+Dox) towards 
normal cells (human lymphocytes) using the comet 
assay technique.
Materials and Methods
????????? ???????????? ???? ??????????????????
A highly stable reproducible pristine C60 fullerene 
aqueous colloid solution (C60FAS) in concentration 
0.15 mg/ml was prepared according to protocol de-
scribed in [27, 28]. 
Dox (Doxorubicin-TEVA, Pharmachemie B.V., 
10 mg of lyophilized powder) dissolved in physiolog-
ical solution (0.9% NaCl), with an initial concentra-
tion 0.15 mg/ml was used. 
????????????????????????????60 fullerene ac-
???????? ??? ????????? ????????? ??????????????? ?????
C60 fullerene may act as an effective carrier of the 
antibiotic molecules (three Dox molecules per C60
fullerene), protecting them from water environ-
ment [25]: C60FAS (0.15 mg/ml) and Dox solution 
(0.15 mg/ml) were mixed in 1:2 (volume ratio). The 
resulting mixture was treated for 20 min in the ul-
trasonic disperser, and then left for 12 h of magnetic 
stirring at room temperature. The absorption spectra 
of Dox solution and C60+Dox mixture were meas-
ured in the wavelength range from 400 to 600 nm 
at room temperature. The pronounced hypochromic 
effect observed in the experiment indicates the for-
mation of a stable complex between Dox and C60
fullerene [25]. 
The structural state of C60 fullerene, Dox, as 
well as C60+Dox complex, in aqueous solutions 
was monitored using the atomic-force microscopy 
(AFM) on “Solver Pro M” system (NT-MDT, Rus-
sian Federation). A sample was deposited onto a 
cleaved mica substrate (V-1 Grade, SPI Supplies) by 
precipitation from a droplet of aqueous solution. The 
sample visualization was carried out in semi-contact 
(tapping) mode, and NSG10 (NT-MDT) probes were 
used. AFM measurements were performed after a 
complete evaporation of the solvent.
Comet assay. Human lymphocytes were ob-
???????????????????????????????????????????????????
separation of cells in a density gradient Histopaque 
1077 (Sigma, USA) according to instructions of the 
manufacturer and then washed in 0.15 M NaCl twice. 
After washing, 200 µl of cell suspension were shared 
equally into four parts and each aliquot was mixed 
with 250 µl of RPMI 1640 medium. C60 fullerene, 
anticancer drug Dox, and complex of C60 fullerene 
with Dox were added at different concentrations to 
the lymphocyte suspensions in RPMI 1640 medium. 
The cells were incubated in the presence of these 
agents for 1 hour at 37 ºC and then washed once in 
0.15 M NaCl. The suspension in the amount of 50 µl 
was mixed with 100 µl of 1% low-melting point aga-
rose (Sigma, USA) at ~37 ºC; 20 µl of the mixture 
were used to prepare a microscope slide covered 
with 1% high-melting point agarose.
Slides were kept for 3-5 min at room tempera-
ture until agarose polymerization and then placed 
????????????????????????????????????????????????
??????????????? ???? ?????? ???? ????????????????
(Ferak, Germany) which was added before use. 
Cells were exposed to lysis solution for 2 hours at 
4 ºC. After the lysis, slides were washed with TBE 
??????????? ?????????????????????????????????????
subjected to electrophoresis in the same buffer for 
20 min at 4 ºC (1 V/cm, 300 mA).
After electrophoresis, slides were stained with 
???????????????????????????????????????????????
?????????????????????????????????????? ???????
Russia) connected with Canon A570 camera (a total 
100 to 200 cells on each slide were analyzed). The 
relative amount of DNA in the comet tail, the pa-
???????????????????????????????????????????????????
determined using image analysis softwares Comet 
Assay IV (Perspective Instruments, UK) and Com-
etScore (TriTec Corp., USA). Statistical analysis of 
the experimental data was performed using Student 
t????????????????????????????????????P?????????
Results and Discussion
Structure of C60  fullerene, Dox and their com-
???????????????????????????????????????? AFM study 
of C60 fullerenes precipitated from their aqueous so-
lution revealed that C60 molecules arranged singly 
(~0.7 nm in diameter) or in the form of their volume 
aggregates up to 60 nm in diameter (Fig. 1, a). 
From the solution containing 0.15 M NaCl, C60
fullerenes precipitate in the form of 'island-like' ag-
gregates, with the height no more than 0.7 nm spread 
on the surface (Fig. 1, b). NaCl crystals can be seen 
in Fig 1, b as white area, i.e. they have much larger 
height.
At water evaporation from the Dox solution 
????????????? ?????????? ??? ?????60 fullerene con-
taining NaCl, a non-homogeneous distribution of 
the precipitated material on the mica surface was 
observed. NaCl crystals were localized in the ‘salt’ 
???????????????????????
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spot, which was clearly seen under optical micro-
scope. The area of the spot occupies ~50% of the 
whole surface initially covered by the solution. It 
was established that the main fraction of NaCl and 
the studied compounds, i.e. Dox or C60 fullerene, 
is localized within the ‘salt’ spot (the range of high 
concentration). In this region Dox molecules form 
ordered long-chain branched nanostructures with 
6-20 nm height (Fig. 2, region I). In the vicinity of 
Dox, one can notice the nanocrystals of salt from 
physiological solution which are seen on the picture 
as white points (Fig. 2, region II). The height of these 
nanocrystals is approximately ~35 nm.
????????? ???? ??????????60 fullerene with Dox 
mixture showed that in the range of high concentra-
tion its structure is similar to that of the Dox layer 
(see Figs. 2 and 3). In the region of the surface away 
of the ‘salt’ spot (the range of low concentration), 
the structure of the layer of C60+Dox containing 
system is seen as an island-like structure (Fig. 4), 
which is quite similar to the structure of C60 fullere-
ne precipitated alone from the salt solution (Fig. 1, 
b). In contrast to C60 fullerene alone, the height of the 
observed islands formed in the presence of Dox is 
larger than 1 nm (Fig. 4). This implies the formation 
???????????????????????????60 fullerene with Dox. 
Recent studies [25] have shown that three Dox mole-
cules may simultaneously bind to one C60 molecule 
without sterical overlapping so that the diameter of 
such complex should be about 1.38 nm. 
Fig. 1. AFM image of C60????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????? ?????????
Fig. 2. AFM image of Dox (0.15 mg/ml concentra-
?????? ????????????? ????? ???? ???????? ????????? ???-
taining 0.15 M NaCl. High concentration range 
????????????????????????????????????????????????????-
??????????? ????????????????????????????? ???????? ???
and salt (region II) are indicated
a b
Genotoxicity of C60 fullerene, Dox and their 
???????? Genotoxicity of C60 fullerene and Dox was 
tested using the comet assay. Several representative 
images of comets obtained after 20 min of electro-
phoresis of intact lymphocytes and cells treated with 
C60 fullerene, Dox, or their complex are shown in 
Fig. 5. In control experiments, when isolated cells 
were incubated in RPMI 1640 medium containing 
?????????????????????????????????????????????????et al.
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Fig. 3. AFM image of C60+Dox mixture (0.15 mg/ml 
of C60????????????????????????????????????????????????
??? ???? ????? ?????????? ????? ???? ???????? ?????????
containing 0.15 M NaCl. High concentration range 
???????????????????????????????
Fig. 4. AFM image of C60+Dox mixture (0.15 mg/ml of C60???????????????????? ???????? ????????????????????????
????????????????????????????????????????????????????????????????????????????????????????????????????????
section along the indicated line
common used antibiotics kanamycin and strepto-
mycin, the average relative amount of DNA in the 
comet tails was 0.06 ± 0.01. This value corresponds 
to the DNA damage rate typically observed in intact 
differentiated cells [29, 30]. 
Culturing of lymphocytes with C60 fullerene at 
0.005 mg/ml or 0.015 mg/ml did not change the rate 
of DNA damage, thus, C60 fullerene nanoparticles do 
not possess genotoxic effects in cells (Fig. 6). At low 
Dox concentration (0.01 mg/ml), Dox-treated cells 
showed the DNA damage level comparable with 
???????????????????????????????????????????????????????
of the average relative amount of DNA in comet tails 
up to 0.15 was observed after treatment with Dox at 
0.03 mg/ml (Fig. 6). Anticancer effect of Dox im-
plies two mechanisms of its action [31, 32]. As an 
antibiotic of anthracycline class Dox intercalates 
in DNA and, in this way, blocks DNA replication 
in cells undergoing division and, thus, causes their 
death [31]. Obviously, such effect is essential for di-
viding cells (e. g. cancer cells), not for non-dividing 
lymphocytes. On the other hand, Dox induces an 
appearance of the reactive oxygen species (ROS) in 
treated cells and, thus, may provoke DNA damage 
[31]. This mechanism of DNA damage should be 
valid for both dividing and non-dividing cells. We 
??????? ????????????????????????????? ????????????
Dox upon lymphocyte DNA is related to the ability 
of the drug to induce generation of ROS. Thus, ROS 
concentration in cells depends on Dox concentration 
in the medium.
Numerous studies argue that C60 fullerene na-
noparticles possess an antioxidant activity [2, 19], 
and one may expect that they can reduce mutagenic 
effects of Dox associated with generation of ROS in-
duction. To test this possibility, we investigated the 
DNA damage rate in cells treated with the C60+Dox 
complex (Fig. 6). In the cells treated with the com-
???????????????????????
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??????????????????????????????????????????????????????
DNA in the comet tails in comparison with free Dox 
was observed (in both cases – free Dox and Dox in 
the complex with C60 fullerene – drug concentrations 
were the same). It should be noted that the average 
relative amount of DNA in the comet tails in cells 
???????? ????????????????????????????????????????????????? ???????????????????????????????????????????????????????-
?????????????????????????????????????????60  fullerene at 0.015 µg/ml (2); and with free Dox at 0.03 µg/ml (3) 
??????????????????????????????????? ??? ?????????? ?????? ?????????????????????????????????????????????????????
and cells treated with Dox, C60 fullerene or C60?????????????????????????? ??????? ???? ?????? ????????????
????????????????????????????????????????????????????????????????????????????????????????????????????????????????
????????????P ????????????????????????????????????????
treated with C60+Dox complex was comparable with 
control cells despite a difference in comet morphol-
ogy (Fig. 5). This difference implies that the co-in-
cubation with C60+Dox complex induces slight DNA 
fragmentation in treated cells that leads to comet tail 
formation. Nevertheless, the quantitative analysis 
0.20
0.15
0.10
0.05
0.00
P
Control           Dox       C60 fullerene   C60+Dox
Doxorubicin (Dox) concentration 0.01 μg/ml
C60 fullerene concentration 0.005 μg/ml 
Doxorubicin (Dox) concentration 0.03 μg/ml
C60 fullerene concentration 0.015 μg/ml 
?????????????????????????????????????????????????et al.
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shows the amount of this “migrated DNA” relative to 
all DNA in cells to be very small, i.e. approximately 
on the level of control (Fig. 6). Thus, the results of 
this study show that the C60 fullerene may prevent 
the toxic effects of Dox in normal cells. 
???????? ???????????????? ??? ??????????? ???????-
ganization of C60 fullerene in the presence of Dox 
were studied by using the AFM technique. The ob-
tained results demonstrate the formation of C60+Dox 
complexes. The genotoxicity of the complex was 
estimated in vitro using the comet assay. It was 
found that C60 fullerene nanoparticles do not pos-
sess genotoxic effect towards human lymphocytes. 
Moreover, the results indicate that C60 fullerene in 
such complex prevents the toxic effect of Dox to-
wards normal cells. Thus, the C60+Dox complex can 
be a promising agent used in antitumor therapy.
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